Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Pietrantonio

Showing results (91-100 of 323) with videos related to

Pageof 33
Sort By:
Medical Oncology (Northwood, London, England)|May 24, 2013
Role of BAX for outcome prediction in gastrointestinal malignanciesFilippo Pietrantonio, Pamela Biondani, Elisa Ciurlia, et al.
ESMO Open|March 10, 2020
Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patientsGiovanni Crisafulli, Benedetta Mussolin, Andrea Cassingena, et al.
Medical Oncology (Northwood, London, England)|May 25, 2015
Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastasesFilippo Pietrantonio, Vincenzo Mazzaferro, Rosalba Miceli, et al.
Oncology|January 19, 2013
Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?Chiara Bampo, Alessandra Alessi, Simona Fantini, et al.
Clinical Colorectal Cancer|May 22, 2026
Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal CancerLisa Salvatore, Marwan Fakih, Yasutoshi Kuboki, et al.
Cancers|May 14, 2025
Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future PerspectivesValentino Martelli, Joana Vidal, Sílvia Salvans, et al.
Scientific Reports|September 12, 2019
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS studyGiovanni Fucà, Luigi Mariani, Salvatore Lo Vullo, et al.
Clinical Medicine Insights. Oncology|August 22, 2020
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?Emanuela Dell'Aquila, Tea Zeppola, Marco Stellato, et al.
International Journal of Molecular Sciences|September 6, 2013
Role of cMET in the development and progression of colorectal cancerJuan Carlos Samamé Pérez-Vargas, Pamela Biondani, Claudia Maggi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 23, 2024
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer modelsElisabetta Puliga, Chiara De Bellis, Sandra Vietti Michelina, et al.
Pageof 33

Showing results (91-100 of 323) with videos related to

Sort By:
Pageof 33
Medical Oncology (Northwood, London, England)|May 24, 2013
Role of BAX for outcome prediction in gastrointestinal malignanciesFilippo Pietrantonio, Pamela Biondani, Elisa Ciurlia, et al.
ESMO Open|March 10, 2020
Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patientsGiovanni Crisafulli, Benedetta Mussolin, Andrea Cassingena, et al.
Medical Oncology (Northwood, London, England)|May 25, 2015
Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastasesFilippo Pietrantonio, Vincenzo Mazzaferro, Rosalba Miceli, et al.
Oncology|January 19, 2013
Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?Chiara Bampo, Alessandra Alessi, Simona Fantini, et al.
Clinical Colorectal Cancer|May 22, 2026
Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal CancerLisa Salvatore, Marwan Fakih, Yasutoshi Kuboki, et al.
Cancers|May 14, 2025
Liquid Biopsy in Peritoneal Carcinomatosis from Colorectal Cancer: Current Evidence and Future PerspectivesValentino Martelli, Joana Vidal, Sílvia Salvans, et al.
Scientific Reports|September 12, 2019
Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS studyGiovanni Fucà, Luigi Mariani, Salvatore Lo Vullo, et al.
Clinical Medicine Insights. Oncology|August 22, 2020
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?Emanuela Dell'Aquila, Tea Zeppola, Marco Stellato, et al.
International Journal of Molecular Sciences|September 6, 2013
Role of cMET in the development and progression of colorectal cancerJuan Carlos Samamé Pérez-Vargas, Pamela Biondani, Claudia Maggi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 23, 2024
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer modelsElisabetta Puliga, Chiara De Bellis, Sandra Vietti Michelina, et al.
Pageof 33